keyword
https://read.qxmd.com/read/38635473/human-epidermal-growth-factor-receptor-2-overexpression-amplification-in-primary-ovarian-endometrioid-carcinoma
#1
JOURNAL ARTICLE
Chau M Bui, Aviv Oren, Bonnie Balzer, Horacio Maluf, Fabiola Medeiros
Human epidermal growth factor receptor 2 (HER2) expression has become increasingly helpful in predicting responses to anti-HER2 agents in gynecological cancers. This study retrospectively analyzed HER2 expression in 48 primary ovarian endometrioid carcinomas. HER2 immunohistochemistry was performed using the Ventana platform (Clone 4B5 monoclonal predilute) following the manufacturer's protocol. HER2 expression was equivocal (score 2+) by image analysis in 2 cases (4.17%) based on the breast cancer criteria...
April 18, 2024: Applied Immunohistochemistry & Molecular Morphology: AIMM
https://read.qxmd.com/read/38635421/high-financial-hardship-among-patients-with-advanced-ovarian-cancer
#2
JOURNAL ARTICLE
Elsa Maria Vasquez-Trespalacios, Jessica N Rivera Rivera, McKenzie McIntyre, Waleska Santiago-Datil, Robert M Wenham, Susan T Vadaparampil, Andrea L Buras, Claire C Conley
Ovarian cancer is considered the most fatal and costly gynecologic cancer. Although personalized therapies have improved ovarian cancer prognosis, they have resulted in increased financial toxicity concerns among this population. This study evaluated financial toxicity in patients with advanced ovarian cancer. Using secondary data from a study of barriers to palliative care, financial toxicity (FT) was measured through the Comprehensive Score for Financial Toxicity scale. Univariate and bivariate analyses were used to assess the relationship between selected demographic (i...
April 18, 2024: Journal of Social Work in End-of-life & Palliative Care
https://read.qxmd.com/read/38634898/real-world-prevalence-of-microsatellite-instability-testing-and-related-status-in-women-with-advanced-endometrial-cancer-in-europe
#3
JOURNAL ARTICLE
Sneha S Kelkar, Vimalanand S Prabhu, Jingchuan Zhang, Yoscar M Ogando, Kyle Roney, Rishi P Verma, Nicola Miles, Christian Marth
PURPOSE: To assess the real-world prevalence of microsatellite instability (MSI)/mismatch repair (MMR) testing and related tumor status in recurrent/advanced endometrial cancer patients in Europe. METHODS: Data were from two multi-center, retrospective patient chart review studies conducted in the United Kingdom, Germany, Italy, France and Spain: The Endometrial Cancer Health Outcomes-Europe-First-Line (ECHO-EU-1L) study and the ECHO-EU-Second-Line (ECHO-EU-2L) study...
April 18, 2024: Archives of Gynecology and Obstetrics
https://read.qxmd.com/read/38634055/risk-factors-associated-with-false-negative-rate-of-sentinel-lymph-node-biopsy-in-endometrial-cancer-a-systematic-review-and-meta-analysis
#4
REVIEW
Meng-Si Fan, Ke-Xin Qiu, Dong-Yue Wang, Hao Wang, Wei-Wei Zhang, Li Yan
OBJECTIVE: Currently, sentinel lymph node biopsy (SLNB) is increasingly used in endometrial cancer, but the rate of missed metastatic lymph nodes compared to systemic lymph node dissection has been a concern. We conducted a systematic review and meta-analysis to evaluate the false negative rate (FNR) of SLNB in patients with endometrial cancer and to explore the risk factors associated with this FNR. DATA SOURCES: Three databases (PubMed, Embase, Web of Science) were searched from initial database build to January 2023 by two independent reviewers...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38633878/the-impact-of-job-stress-on-perceived-professional-benefits-among-chinese-nurses-caring-for-patients-with-gynecological-cancer-mediating-effects-of-perceived-social-support-and-self-efficacy
#5
JOURNAL ARTICLE
Yuxin Zhang, Xinhai Meng, Lihua Zhou
INTRODUCTION: Nurses caring for patients with gynecological cancer experience significant job stress, which adversely impacts their mental health. Previous studies have indicated that perceived professional benefits serves as a protective factor for nurses' mental health, and factors such as job stress, perceived social support and self-efficacy influence their perceived professional benefits. However, the relationships between these factors and the associated mechanisms have remained incompletely understood...
2024: Frontiers in Psychology
https://read.qxmd.com/read/38633674/molecular-profiling-of-primary-endometrioid-endometrial-cancer-and-matched-lung-metastases-ctnnb1-mutation-as-a-potential-driver
#6
Sushmita Gordhandas, Arnaud Da Cruz Paula, Elizabeth C Kertowidjojo, Fresia Pareja, Kimberly Dessources, Edaise M da Silva, Fatemeh Derakhshan, Jennifer J Mueller, Nadeem R Abu-Rustum, M Herman Chui, Britta Weigelt
•Both primary endometrial cancers (ECs) and matched lung metastases shared a common ancestor with independent evolution at each site.•The two endometrioid ECs studied acquired additional mutations during the distant metastatic process.•Subclonal CTNNB1 hotspot mutations in the two primary ECs studied became clonal in the distant metastases.
June 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38633673/pembrolizumab-with-bevacizumab-and-cyclophosphamide-for-the-treatment-of-recurrent-ovarian-clear-cell-carcinoma-a-case-series
#7
Shannon M Glynn, Stephanie Gaillard, Rebecca L Stone, Amanda N Fader, Anna L Beavis
INTRODUCTION: Treatment for recurrent ovarian clear cell carcinoma (OCCC) is clinically challenging as response rates to traditional chemotherapy are low, and recurrence rates are high. Immunotherapy has shown promise for this ovarian cancer (OC) subtype, and tumor molecular testing allows for the identification of a patient population that might benefit most from this treatment. We describe the clinical course and somatic genomic testing of 4 patients who received pembrolizumab for recurrent OCCC concurrent with a combination of bevacizumab and/or cyclophosphamide...
June 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38633671/maximizing-ovarian-function-and-fertility-following-chemotherapy-in-premenopausal-patients-is-there-a-role-for-ovarian-suppression
#8
REVIEW
Kelsey A Roof, Kerri E Andre, Susan C Modesitt, D Austin Schirmer
As more premenopausal patients undergo fertility preserving cancer treatments, there is an increased need for fertility counseling and ovarian sparing strategies. Many patients receive gonadotoxic chemotherapeutic agents which can put them at risk of primary ovarian insufficiency or profoundly diminished ovarian reserve. Traditionally, estradiol and follicle stimulating hormone (FSH) values have been used to evaluate ovarian function but more recently, reproductive endocrinologists have been proponents of anti-mullerian hormone (AMH) as a validated measure of ovarian potential...
June 2024: Gynecologic Oncology Reports
https://read.qxmd.com/read/38633571/the-effect-of-tamoxifen-citrate-on-granulosa-cells-of-ovarian-follicles-in-adult-female-rats-light-microscopic-study
#9
JOURNAL ARTICLE
Fatimah Khalil Aljassim, Amal Ahmed El-Sheikh, Mohamed A Motabagani
BACKGROUND: Tamoxifen is a drug that has been used extensively as a chemotherapeutic agent for breast cancer. It should be taken for a long period, from few weeks up to many years, so it can induce gynecological and nongynecological complications. AIM: Present study was conducted to clarify the histopathological effects of tamoxifen intake on the ovarian follicles of rats and evaluate the promising recovery after drug withdrawal. MATERIALS AND METHODS: Adult female albino rats ( n = 24) were randomly divided into four groups...
2024: Journal of Microscopy and Ultrastructure
https://read.qxmd.com/read/38633411/highly-specific-vaginal-microbiome-signature-for-gynecological-cancers
#10
JOURNAL ARTICLE
Mengzhen Han, Na Wang, Wenjie Han, Xiaolin Liu, Tao Sun, Junnan Xu
To investigate the vaginal microbiota signature of patients with gynecologic cancer and evaluate its diagnostic biomarker potential. We incorporated vaginal 16S rRNA-seq data from 529 women and utilized VSEARCH to analyze the raw data. α-Diversity was evaluated utilizing the Chao1, Shannon, and Simpson indices, and β-diversity was evaluated through principal component analysis using Bray-Curtis distances. Linear discriminant analysis effect size (LEfSe) was utilized to determine species differences between groups...
2024: Open Life Sciences
https://read.qxmd.com/read/38631739/moving-toward-personalized-medicine-in-gynecologic-cancers
#11
EDITORIAL
Michelle Ludwig, Neil Taunk, Junzo Chino, Lara Hathout, Eric Leung, Emma Fields
No abstract text is available yet for this article.
May 1, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38631506/concordance-between-preoperative-imaging-methods-in-patients-with-limb-lymphedema-undergoing-supermicrosurgical-lymphaticovenular-anastomosis
#12
JOURNAL ARTICLE
Anna Amelia Caretto, Girolamo Tartaglione, Francesco Pio Ieria, Chiara Colavincenzo, Stefano Gentileschi
OBJECTIVE: Supermicrosurgical lymphaticovenular anastomosis (LVA) is increasingly being recognized as a first-line treatment for limb lymphedema because it is minimally invasive and highly effective. Lymphoscintigraphy and indocyanine green (ICG) lymphography are the two most commonly performed diagnostic imaging examinations to establish the indication and plan the procedure in patients affected by limb lymphedema. In a small group of patients, the information between these two imaging tools can be discordant, showing different anatomical drainage pathways or showing absence of drainage and dermal backflow in one examination, and valid drainage pathways in the other...
April 15, 2024: Journal of Vascular Surgery. Venous and Lymphatic Disorders
https://read.qxmd.com/read/38628996/a-rare-case-report-of-dedifferentiated-endometrioid-carcinoma
#13
Vallal Kani, Sumithra A, Jayaganesh P, Dhanya Menon
Dedifferentiated endometrioid carcinoma (DEC) is an exceptionally rare subtype of endometrial cancer characterized by a high-grade component juxtaposed with a low-grade endometrioid adenocarcinoma. This case report presents a unique instance of dedifferentiated endometrioid carcinoma in a 64-year-old female patient who presented with post-menopausal bleeding and abdominal pain. Diagnostic evaluation including imaging studies and histopathological examination revealed a mixed tumor comprising both high-grade and low-grade components...
March 2024: Curēus
https://read.qxmd.com/read/38628280/post-traumatic-growth-in-oncological-patients-during-the-covid-19-pandemic
#14
JOURNAL ARTICLE
Letizia Lafuenti, Loredana Dinapoli, Ludovica Mastrilli, Vezio Savoia, Marinella Linardos, Riccardo Masetti, Giampaolo Tortora, Vincenzo Valentini, Giovanni Scambia, Daniela P R Chieffo
BACKGROUND: Post-traumatic growth (PTG) is defined as "positive psychological change experienced as a result of the struggle with highly challenging life circumstances". Diagnosis of cancer leads to many psychological challenges. The recent pandemic forced oncological patients to face other multiple stressors. Resilience is a target of interest for PTG. The aim of this study is to analyze relationships between cancer trauma, COVID-19 pandemic stress, PTG and resilience over time. PARTICIPANTS AND PROCEDURE: One hundred forty-six patients (124 females, 22 males) in active oncological treatment were enrolled from September 2020: 45...
2024: Health Psychology Report
https://read.qxmd.com/read/38627856/comprehensive-dna-methylation-profiling-by-medip-ngs-identifies-potential-genes-and-pathways-for-epithelial-ovarian-cancer
#15
JOURNAL ARTICLE
Priyanka Gautam, Sameer Gupta, Manisha Sachan
Ovarian cancer, among all gynecologic malignancies, exhibits the highest incidence and mortality rate, primarily because it is often presents with non-specific or no symptoms during its early stages. For the advancement of Ovarian Cancer Diagnosis, it is crucial to identify the potential molecular signatures that could significantly differentiate between healthy and ovarian cancerous tissues and can be used further as a diagnostic biomarker for detecting ovarian cancer. In this study, we investigated the genome-wide methylation patterns in ovarian cancer patients using Methylated DNA Immunoprecipitation (MeDIP-Seq) followed by NGS...
April 16, 2024: Journal of Ovarian Research
https://read.qxmd.com/read/38627058/fertility-sparing-approach-in-concurrent-gliomatosis-peritonei-and-growing-teratoma-syndrome-in-a-young-woman
#16
JOURNAL ARTICLE
Siti Nawwal Ahmad Nasfy, Habibah Abdul Hamid, Azalea Md Khairuddin, Maryam Kameelah Mohamad Fauzi
Gliomatosis peritonei (GP) and Growing Teratoma Syndrome (GTS) are rare and clinically significant conditions often associated with ovarian teratomas. GP involves the development of benign glial implants on the peritoneal surface, while GTS is characterised by the growth of benign, yet enlarging peritoneal implants following chemotherapy for malignant germ cell tumours. These implants are typically histologically mature teratomas devoid of malignancy. Our report documents a unique case where both GP and GTS manifested in a patient undergoing treatment for an immature ovarian teratoma...
April 16, 2024: BMJ Case Reports
https://read.qxmd.com/read/38627036/low-serum-creatinine-levels-are-associated-with-major-post-operative-complications-in-patients-undergoing-surgery-with-gynecologic-oncologists
#17
JOURNAL ARTICLE
Connor C Wang, Sonya Bharadwa, Olivia W Foley, Issac Domenech, Brenda Vega, Mary Towner, Emma L Barber
OBJECTIVE: Serum creatinine is a byproduct of muscle metabolism, and low creatinine is postulated to be associated with diminished muscle mass. This study examined the association between low pre-operative serum creatinine and post-operative outcomes. METHODS: This retrospective cohort study utilized the 2014-2021 National Surgical Quality Improvement Program to identify patients undergoing surgery with gynecologic oncologists. Patients with missing pre-operative creatinine, end-stage renal disease, sepsis, septic shock, dialysis, or pregnancy were excluded...
April 16, 2024: International Journal of Gynecological Cancer
https://read.qxmd.com/read/38627035/engot-en20-gog-3083-xport-ec-042-a-phase-iii-randomized-placebo-controlled-double-blind-multicenter-trial-of-selinexor-in-maintenance-therapy-after-systemic-therapy-for-patients-with-p53-wild-type-advanced-or-recurrent-endometrial-carcinoma-rationale-methods
#18
JOURNAL ARTICLE
Ignace Vergote, Alejandro Perez Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon van Gorp, Debra Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian Slomovitz, Robert L Coleman
BACKGROUND: Patients with advanced/recurrent endometrial cancer have a poor prognosis and limited treatment options. Biomarkers such as tumor protein 53 ( TP53 ) in endometrial cancer can integrate novel strategies for improved and individualized treatment that could impact patient outcomes. In an exploratory analysis of the phase III ENGOT-EN5/GOG-3055/SIENDO study of selinexor maintenance monotherapy 80 mg in advanced/recurrent endometrial cancer, a pre-specified subgroup of patients with TP53 wild type (wt) endometrial cancer showed preliminary activity at long-term follow-up with a generally manageable safety profile (median progression-free survival 27...
April 16, 2024: International Journal of Gynecological Cancer
https://read.qxmd.com/read/38627034/role-of-fertility-sparing-surgery-and-further-prognostic-factors-in-borderline-tumors-of-the-ovary
#19
JOURNAL ARTICLE
Timo Westermann, Edin Karabeg, Florian Heitz, Alexander Traut, Helmut Plett, Malak Moubarak, Julia Welz, Sebastian Heikaus, Sigurd Lax, Andreas du Bois, Philipp Harter
OBJECTIVE: Borderline tumors of the ovary are a rare group of ovarian neoplasms with distinctive histological features. Considering their favorable prognosis and occurrence at a younger age, fertility-sparing surgery may be considered. Several risk factors have been identified as contributing to a higher recurrence rate, while the impact of pathohistological features varies in the literature. This study aimed to analyze risk factors for recurrence in patients with borderline tumors of the ovary...
April 16, 2024: International Journal of Gynecological Cancer
https://read.qxmd.com/read/38627033/tumoral-clearance-of-the-right-portal-hilar-area-surprises-beyond-no-visual-disease
#20
JOURNAL ARTICLE
Ghanim Khatib, Emine Gulen Kucukbingoz, İrem Hatipoglu, Mehmet Ali Vardar
No abstract text is available yet for this article.
April 16, 2024: International Journal of Gynecological Cancer
keyword
keyword
3314
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.